Editorial
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia
Inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (iPCSK9). Los nuevos de la clase en el tratamiento de la hipercolesterolemia
Read
4339
Timeswas read the article
737
Total PDF
3602
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 22 | 12 | 34 |
| 2025 11 | 73 | 24 | 97 |
| 2025 10 | 56 | 16 | 72 |
| 2025 9 | 32 | 12 | 44 |
| 2025 8 | 43 | 12 | 55 |
| 2025 7 | 111 | 11 | 122 |
| 2025 6 | 36 | 1 | 37 |
| 2025 5 | 42 | 4 | 46 |
| 2025 4 | 29 | 5 | 34 |
| 2025 3 | 51 | 5 | 56 |
| 2025 2 | 56 | 6 | 62 |
| 2025 1 | 65 | 4 | 69 |
| 2024 12 | 39 | 4 | 43 |
| 2024 11 | 31 | 7 | 38 |
| 2024 10 | 28 | 2 | 30 |
| 2024 9 | 29 | 19 | 48 |
| 2024 8 | 24 | 9 | 33 |
| 2024 7 | 23 | 9 | 32 |
| 2024 6 | 31 | 2 | 33 |
| 2024 5 | 24 | 2 | 26 |
| 2024 4 | 27 | 32 | 59 |
| 2024 3 | 49 | 6 | 55 |
| 2024 2 | 58 | 7 | 65 |
| 2024 1 | 35 | 4 | 39 |
| 2023 12 | 56 | 6 | 62 |
| 2023 11 | 41 | 4 | 45 |
| 2023 10 | 69 | 9 | 78 |
| 2023 9 | 19 | 3 | 22 |
| 2023 8 | 27 | 2 | 29 |
| 2023 7 | 55 | 4 | 59 |
| 2023 6 | 46 | 5 | 51 |
| 2023 5 | 90 | 2 | 92 |
| 2023 4 | 87 | 4 | 91 |
| 2023 3 | 45 | 2 | 47 |
| 2023 2 | 40 | 3 | 43 |
| 2023 1 | 21 | 7 | 28 |
| 2022 12 | 34 | 6 | 40 |
| 2022 11 | 20 | 10 | 30 |
| 2022 10 | 17 | 14 | 31 |
| 2022 9 | 20 | 10 | 30 |
| 2022 8 | 25 | 8 | 33 |
| 2022 7 | 27 | 7 | 34 |
| 2022 6 | 45 | 8 | 53 |
| 2022 5 | 55 | 5 | 60 |
| 2022 4 | 69 | 8 | 77 |
| 2022 3 | 107 | 6 | 113 |
| 2022 2 | 96 | 6 | 102 |
| 2022 1 | 98 | 3 | 101 |
| 2021 12 | 93 | 8 | 101 |
| 2021 11 | 61 | 15 | 76 |
| 2021 10 | 33 | 8 | 41 |
| 2021 9 | 40 | 12 | 52 |
| 2021 8 | 30 | 9 | 39 |
| 2021 7 | 18 | 12 | 30 |
| 2021 6 | 23 | 21 | 44 |
| 2021 5 | 28 | 9 | 37 |
| 2021 4 | 89 | 35 | 124 |
| 2021 3 | 56 | 5 | 61 |
| 2021 2 | 73 | 10 | 83 |
| 2021 1 | 72 | 8 | 80 |
| 2020 12 | 46 | 10 | 56 |
| 2020 11 | 37 | 5 | 42 |
| 2020 10 | 19 | 6 | 25 |
| 2020 9 | 15 | 5 | 20 |
| 2020 8 | 38 | 6 | 44 |
| 2020 7 | 32 | 11 | 43 |
| 2020 6 | 27 | 8 | 35 |
| 2020 5 | 50 | 10 | 60 |
| 2020 4 | 17 | 3 | 20 |
| 2020 3 | 25 | 3 | 28 |
| 2020 2 | 24 | 4 | 28 |
| 2020 1 | 33 | 2 | 35 |
| 2019 12 | 28 | 2 | 30 |
| 2019 11 | 33 | 17 | 50 |
| 2019 10 | 25 | 3 | 28 |
| 2019 9 | 24 | 3 | 27 |
| 2019 8 | 15 | 8 | 23 |
| 2019 7 | 23 | 18 | 41 |
| 2019 6 | 41 | 23 | 64 |
| 2019 5 | 76 | 37 | 113 |
| 2019 4 | 49 | 19 | 68 |
| 2019 3 | 3 | 4 | 7 |
| 2019 2 | 7 | 2 | 9 |
| 2019 1 | 5 | 4 | 9 |
| 2018 12 | 2 | 2 | 4 |
| 2018 11 | 7 | 6 | 13 |
| 2018 10 | 8 | 1 | 9 |
| 2018 9 | 6 | 5 | 11 |
| 2018 8 | 5 | 0 | 5 |
| 2018 7 | 10 | 0 | 10 |
| 2018 6 | 3 | 0 | 3 |
| 2018 5 | 7 | 0 | 7 |
| 2018 4 | 4 | 0 | 4 |
| 2018 3 | 9 | 0 | 9 |
| 2018 2 | 5 | 0 | 5 |
| 2018 1 | 5 | 1 | 6 |
Show all
